Myomo Inc. CEO Steve Kelly on his company’s portable, robotic device for stroke rehabilitation and the coming wave that will revolutionize the medical device industry as we know it.
Myomo Inc
Weekly Wireless Roundup: Myomo launches Android-supported robotic stroke rehab device
Myomo launches Android-supported robotic stroke rehab device:
How do you enhance brain plasticity in patients recovering from stroke, so to improve their motor functions?
This is the question that Cambridge, Mass.-based Myomo Inc., the maker of an upcoming mPower 1000 neuro-robotic arm brace, is trying to answer.
Mass. Life Sciences Center doles out another $3.8 million in loans
MASSDEVICE ON CALL — The Mass. Life Sciences Center, a quasi-public agency that oversees state dollars allocated toward increasing the life sciences industry’s footprint in the Bay State, doled out another $3.8 million in “accelerator” loans.
The program is designed to provide a boost to early-stage life science companies that the center’s scientific advisory board deems to have a high potential for commercialization, rapid growth and the ability to raise substantial capital.
MassDevice Q&A: Myomo CEO Steve Kelly
Steve Kelly’s spent three decades watching new technology that originated in consumer electronics wreak havoc on well-established industries. The CEO of Myomo Inc. bore witness as new technologies redefined the home computing market in the 1980s, the telecom space in the 1990s and the changes voice-over-IP technology brought to telephony in the last decade.
Kelly sees a similar wave heading for the shores of the medical device industry. MassDevice spoke with him to hear his take on where the sector is headed and why.
Medical device makers drum up $2.5 million in December equity, debt sales
Five medical device makers based in New England together raised more than $2.5 million in debt and equity sales, according to filings with the Securities and Exchange Commission.
BioBehavioral Diagnostics Co., Cardiosolutions Inc., Echo Therapeutics Inc., Eleme Medical Inc. and Myomo Inc. all sold debt or equity for an average net return of about $500,000 last month: